Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.
Ohtsu A, Ajani JA, Bai YX, Bang YJ, Chung HC, Pan HM, Sahmoud T, Shen L, Yeh KH, Chin K, Muro K, Kim YH, Ferry D, Tebbutt NC, Al-Batran SE, Smith H, Costantini C, Rizvi S, Lebwohl D, Van Cutsem E. Ohtsu A, et al. Among authors: chin k. J Clin Oncol. 2013 Nov 1;31(31):3935-43. doi: 10.1200/JCO.2012.48.3552. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043745 Free PMC article. Clinical Trial.
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).
Narahara H, Iishi H, Imamura H, Tsuburaya A, Chin K, Imamoto H, Esaki T, Furukawa H, Hamada C, Sakata Y. Narahara H, et al. Among authors: chin k. Gastric Cancer. 2011 Mar;14(1):72-80. doi: 10.1007/s10120-011-0009-5. Epub 2011 Feb 23. Gastric Cancer. 2011. PMID: 21340666 Free PMC article. Clinical Trial.
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
Yamaguchi K, Sawaki A, Doi T, Satoh T, Yamada Y, Omuro Y, Nishina T, Boku N, Chin K, Hamamoto Y, Takiuchi H, Komatsu Y, Saji S, Koizumi W, Miyata Y, Sato A, Baba E, Tamura T, Abe T, Ohtsu A. Yamaguchi K, et al. Among authors: chin k. Gastric Cancer. 2013 Apr;16(2):175-82. doi: 10.1007/s10120-012-0167-0. Epub 2012 Jul 11. Gastric Cancer. 2013. PMID: 22782463 Free PMC article. Clinical Trial.
Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens.
Oba M, Chin K, Kawazoe Y, Takagi K, Ogura M, Shinozaki E, Suenaga M, Matsusaka S, Mizunuma N, Hatake K. Oba M, et al. Among authors: chin k. Oncol Lett. 2011 Mar;2(2):241-245. doi: 10.3892/ol.2011.242. Epub 2011 Jan 20. Oncol Lett. 2011. PMID: 22866071 Free PMC article.
A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).
Kataoka K, Tsushima T, Mizusawa J, Hironaka S, Tsubosa Y, Kii T, Shibuya Y, Chin K, Katayama H, Kato K, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group. Kataoka K, et al. Among authors: chin k. Jpn J Clin Oncol. 2015 May;45(5):494-8. doi: 10.1093/jjco/hyv012. Epub 2015 Feb 2. Jpn J Clin Oncol. 2015. PMID: 25646357 Clinical Trial.
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study.
Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, Terashima M, Kawashima Y, Fukunaga T, Gotoh M, Emi Y, Yoshida K, Oki E, Takahashi S, Kuriki H, Sato K, Sasako M. Fuse N, et al. Among authors: chin k. Gastric Cancer. 2017 Mar;20(2):332-340. doi: 10.1007/s10120-016-0606-4. Epub 2016 Mar 8. Gastric Cancer. 2017. PMID: 26956689 Free PMC article. Clinical Trial.
2,270 results